Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Immunovaccine Inc.
DescriptionVaccine containing respiratory syncytial virus (RSV) SHe antigen and formulated with the DepoVax vaccine delivery system
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsVaccinate against respiratory syncytial virus (RSV) infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today